Product References
Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?
The American journal of surgical pathology
Hes O,Condom Mundo E,Peckova K,Lopez JI,Martinek P,Vanecek T,Falconieri G,Agaimy A,Davidson W,Petersson F,Bulimbasic S,Damjanov I,Jimeno M,Ulamec M,Podhola M,Sperga M,Pane Foix M,Shelekhova K,Kalusova K,Hora M,Rotterova P,Daum O,Pivovarcikova K,Michal M
324000 was used in immunohistochemistry - paraffin section to characterize 21 cases of biphasic squamoid alveolar renal cell carcinoma
Sun May 01 00:00:00 UTC 2016
HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway.
Nucleic acids research
Xue M,Yao S,Hu M,Li W,Hao T,Zhou F,Zhu X,Lu H,Qin D,Yan Q,Zhu J,Gao SJ,Lu C
Published figure using P-cadherin monoclonal antibody (Product # 32-4000) in Immunohistochemistry
Mon Sep 01 00:00:00 UTC 2014
Novel three-dimensional in vitro models of ovarian endometriosis.
Journal of ovarian research
Brueggmann D,Templeman C,Starzinski-Powitz A,Rao NP,Gayther SA,Lawrenson K
32-4000 was used in western blot to develop and characterize a novel three-dimensional cell culture model of ovarian endometriosis.
Thu Feb 06 00:00:00 UTC 2014
P-cadherin is a direct PAX3-FOXO1A target involved in alveolar rhabdomyosarcoma aggressiveness.
Oncogene
Thuault S,Hayashi S,Lagirand-Cantaloube J,Plutoni C,Comunale F,Delattre O,Relaix F,Gauthier-Rouvière C
32-4000 was used in immunocytochemistry and western blot to elucidate alveolar rhabdomyosarcoma pathogenesis.
Thu Apr 11 00:00:00 UTC 2013
P-cadherin is a direct PAX3-FOXO1A target involved in alveolar rhabdomyosarcoma aggressiveness.
Oncogene
Thuault S,Hayashi S,Lagirand-Cantaloube J,Plutoni C,Comunale F,Delattre O,Relaix F,Gauthier-Rouvière C
32-4000 was used in immunocytochemistry and western blot to elucidate alveolar rhabdomyosarcoma pathogenesis.
Thu Apr 11 00:00:00 UTC 2013
A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro.
Laboratory investigation; a journal of technical methods and pathology
Lee JM,Mhawech-Fauceglia P,Lee N,Parsanian LC,Lin YG,Gayther SA,Lawrenson K
32-4000 was used in western blot to compare the histological, biological, and molecular features of 2D and 3D epithelial ovarian cancer cultures.
Wed May 01 00:00:00 UTC 2013
Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
Virchows Archiv : an international journal of pathology
Petersson F,Gatalica Z,Grossmann P,Perez Montiel MD,Alvarado Cabrero I,Bulimbasic S,Swatek A,Straka L,Tichy T,Hora M,Kuroda N,Legendre B,Michal M,Hes O
32-4000 was used in immunohistochemistry - paraffin section to study the clinicopathologic features of 14 cases of sporadic hybrid oncocytic/chromophobe tumor of the kidney
Thu Apr 01 00:00:00 UTC 2010
JNK signaling pathway is required for bFGF-mediated surface cadherin downregulation on HUVEC.
Experimental cell research
Wu JC,Yan HC,Chen WT,Chen WH,Wang CJ,Chi YC,Kao WY
32-4000 was used in western blot to find that basic fibroblast growth factor downregulates typical cadherin expression on the surface of human umbilical vein endothelial cells via FGF receptor 1 signaling
Fri Feb 01 00:00:00 UTC 2008
Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: possible involvement of cadherins.
Journal of the Society for Gynecologic Investigation
Hanekamp EE,Gielen SC,De Ruiter PE,Chadha-Ajwani S,Huikeshoven FJ,Burger CW,Grootegoed JA,Blok LJ
32-4000 was used in western blot to assess if selective loss of progesterone receptor A or B affects the invasive capacity of endometrial cancer cells
Sun May 01 00:00:00 UTC 2005